Profiel
Mark-Andre Freyberg is the founder of Dermatools Biotech GmbH (founded in 2004), Cytopharma GmbH (founded in 2006), and bioXXmed AG (founded in 2000).
At bioXXmed AG, he held the title of Chief Executive Officer from 2000 to 2021.
Dr. Freyberg's former jobs include Chief Executive Officer at TemplaTech GmbH and Project Manager at Technische Universität Darmstadt.
He earned a doctorate degree from Technische Universität Darmstadt.
Eerdere bekende functies van Mark-Andre Freyberg
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOXXMED AG | Chief Executive Officer | 30-09-2021 |
TemplaTech GmbH
 TemplaTech GmbH BiotechnologyHealth Technology TemplaTech GmbH develops biological medical products. It offers therapy for chronic urinary tract diseases. The company is headquartered in Darmstadt, Germany. | President | 03-09-2007 |
| Dermatools Biotech GmbH | Founder | - |
| Cytopharma GmbH | Founder | - |
| Technische Universität Darmstadt | Corporate Officer/Principal | - |
Opleiding van Mark-Andre Freyberg
| Technische Universität Darmstadt | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIOXXMED AG | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
TemplaTech GmbH
TemplaTech GmbH BiotechnologyHealth Technology TemplaTech GmbH develops biological medical products. It offers therapy for chronic urinary tract diseases. The company is headquartered in Darmstadt, Germany. | Health Technology |
| Dermatools Biotech GmbH | |
| Cytopharma GmbH |
